Journal Article DZNE-2022-00350

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png
Characteristics of subjective cognitive decline associated with amyloid positivity.

 ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;  ;

2022
Wiley Hoboken, NJ

Alzheimer's and dementia 18(10), 1832-1845 () [10.1002/alz.12512]

This record in other databases:    

Please use a persistent id in citations: doi:

Abstract: The evidence for characteristics of persons with subjective cognitive decline (SCD) associated with amyloid positivity is limited.In 1640 persons with SCD from 20 Amyloid Biomarker Study cohort, we investigated the associations of SCD-specific characteristics (informant confirmation, domain-specific complaints, concerns, feelings of worse performance) demographics, setting, apolipoprotein E gene (APOE) ε4 carriership, and neuropsychiatric symptoms with amyloid positivity.Between cohorts, amyloid positivity in 70-year-olds varied from 10% to 76%. Only older age, clinical setting, and APOE ε4 carriership showed univariate associations with increased amyloid positivity. After adjusting for these, lower education was also associated with increased amyloid positivity. Only within a research setting, informant-confirmed complaints, memory complaints, attention/concentration complaints, and no depressive symptoms were associated with increased amyloid positivity. Feelings of worse performance were associated with less amyloid positivity at younger ages and more at older ages.Next to age, setting, and APOE ε4 carriership, SCD-specific characteristics may facilitate the identification of amyloid-positive individuals.

Keyword(s): Humans (MeSH) ; Amyloid (MeSH) ; Amyloidogenic Proteins (MeSH) ; Amyloidosis (MeSH) ; Apolipoprotein E4: genetics (MeSH) ; Biomarkers (MeSH) ; Brain: metabolism (MeSH) ; Cognitive Dysfunction: genetics (MeSH) ; Cognitive Dysfunction: psychology (MeSH) ; Positron-Emission Tomography (MeSH) ; Alzheimer's disease ; amyloid ; cerebrospinal fluid ; positron emission tomography ; subjective cognitive decline

Classification:

Note: (CC BY-NC)

Contributing Institute(s):
  1. Neuropsychology (AG Wagner)
  2. Clinical Alzheimer’s Disease Research (AG Jessen)
  3. Delcode (Delcode)
Research Program(s):
  1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)
Experiment(s):
  1. Longitudinal Cognitive Impairment and Dementia Study

Appears in the scientific report 2022
Database coverage:
Medline ; Creative Commons Attribution-NonCommercial CC BY-NC 4.0 ; OpenAccess ; Clarivate Analytics Master Journal List ; Current Contents - Clinical Medicine ; DEAL Wiley ; Essential Science Indicators ; IF >= 15 ; JCR ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection
Click to display QR Code for this record

The record appears in these collections:
Document types > Articles > Journal Article
Institute Collections > BN DZNE > BN DZNE-AG Jessen
Institute Collections > BN DZNE > BN DZNE-AG Wagner
Institute Collections > M DZNE > M DZNE-Delcode
Full Text Collection
Public records
Publications Database

 Record created 2022-04-11, last modified 2023-09-15


OpenAccess:
Download fulltext PDF Download fulltext PDF (PDFA)
External link:
Download fulltextFulltext by Pubmed Central
Rate this document:

Rate this document:
1
2
3
 
(Not yet reviewed)